脱细胞真皮基质相关挛缩:假体乳房再造患者的临床与组织学分析
该回顾性队列研究纳入46例(92侧)双侧假体乳房再造患者,19侧乳房疑似发生脱细胞真皮基质(ADM)相关挛缩。直接置入假体再造中ADM挛缩较少见(4.2% vs 26.5%,p=0.020),而血清肿(0% vs 15.8%,p=0.001)或需早期更换扩张器的并发症更常见。挛缩的ADM血管化更少、I型/III型胶原比值更低且厚度为非挛缩ADM的两倍。
要点
- 直接置入假体再造的ADM挛缩发生率低于两阶段扩张器再造(4.2% vs 26.5%,p=0.020)。
- 血清肿与ADM挛缩显著相关(0% vs 15.8%,p=0.001)。
- 挛缩ADM组织学表现为血管化减少、I/III型胶原比值降低及厚度增加。
核心结论
- ADM相关挛缩是假体乳房再造中使用ADM的一小部分乳房中出现的独立现象,需进一步研究。
研究设计与样本
- 回顾性队列研究,纳入同一资深术者(M.S.A.)施行的所有双侧假体乳房再造患者,排除接受乳房放疗者,共46例(92侧乳房)。
主要发现
- 19侧乳房疑似ADM相关挛缩。
- 直接置入假体再造中ADM挛缩较少见(4.2% vs 26.5%,p=0.020)。
- 有血清肿的乳房ADM挛缩更常见(0% vs 15.8%,p=0.001)。
- 需早期更换扩张器的并发症与ADM挛缩更常见相关。
- 挛缩ADM血管化更少、I型/III型胶原比值更低,厚度为非挛缩ADM的两倍。
临床怎么用
- 在假体乳房再造中使用ADM时,应警惕ADM相关挛缩,尤其是有血清肿或需早期更换扩张器的患者。
- 直接置入假体再造可能降低ADM挛缩风险,但需结合患者具体情况选择术式。
局限性
- 回顾性研究设计。
- 组织学分析仅来自2例ADM挛缩患者。
- ADM相关挛缩的临床危险因素尚需进一步研究明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Capsular contracture is a well-recognized complication following prosthetic breast reconstruction. It has been the authors' observation that some patients undergoing breast reconstruction experience contracture specifically of the acellular dermal matrix placed at the time of their tissue expander insertion. The goal of the authors' study was to identify clinical and histologic findings associated with the development of acellular dermal matrix-associated contracture. METHODS: The authors performed a retrospective cohort study of all patients undergoing bilateral implant-based breast reconstruction performed by the senior author (M.S.A.). Patients were excluded if they had radiation therapy to the breast. Patients with suspected acellular dermal matrix-associated contracture were identified by clinical photographs and review of operative notes. Histologic analysis was performed on specimens taken from two patients with acellular dermal matrix contracture. RESULTS: The authors included a total of 46 patients (92 breasts), of which 19 breasts had suspected acellular dermal matrix-associated contracture. Acellular dermal matrix contracture was less common in direct-to-implant reconstruction (4.2 percent versus 26.5 percent; p = 0.020) and more common in breasts that had seromas (0 percent versus 15.8 percent; p = 0.001) or complications requiring early expander replacement. Contracted acellular dermal matrix had less vascularity and a lower collagen I-to-collagen III ratio, and was twice as thick as noncontracted acellular dermal matrix. CONCLUSIONS: The authors have described a distinct phenomenon of acellular dermal matrix-associated contracture that occurs in a small subset of breasts where acellular dermal matrix is used. This merits further investigation. Future work will be required to better characterize the clinical factors that make acellular dermal matrix-associated contracture more likely to occur. CLINICAL QUESTION/LEVEL OF EVIDENCE: Risk, III.
引用
- Kearney AM, Yan Y, Bricker JT, et al. Acellular Dermal Matrix-Associated Contracture: A Clinical and Histologic Analysis of Patients Undergoing Prosthetic Breast Reconstruction. Plast Reconstr Surg. 2021. PMID: 34495907. doi:10.1097/PRS.0000000000008485
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。